Displaying 13 - 24 of 41
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure

Overview of HBV antigens and relevance to functional cure

Webcasts
View
Viral Hepatitis
Discussion / Q&A

Discussion / Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
NASH: An evolution in treatment response tools

NASH: An evolution in treatment response tools

Webcasts
View
Viral Hepatitis
Welcome and Introduction

Welcome and Introduction

Webcasts
View
Viral Hepatitis
Plenary – ‘Short Duration DAAs: Fuelling the Journey to HCV Elimination’

Plenary – ‘Short Duration DAAs: Fuelling the Journey to HCV Elimination’

Webcasts
View
Viral Hepatitis
Structured faculty discussion – ‘How Can We Increase the Momentum Towards an HCV-free World?’

Structured faculty discussion – ‘How Can We Increase the Momentum Towards an HCV-free World?’

Webcasts
View
Viral Hepatitis
Audience Q&A and Close

Audience Q&A and Close

Webcasts
View
Viral Hepatitis
Case studies – ‘Best Practices for Optimizing HCV Care’

Case studies – ‘Best Practices for Optimizing HCV Care’

Webcasts
View
Viral Hepatitis
Case studies – ‘Best Practices for Optimizing HCV Care’

Case studies – ‘Best Practices for Optimizing HCV Care’

Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH

Why we need to talk about NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Webcasts
View
Displaying 13 - 24 of 41